1. Home
  2. XGN vs NOTV Comparison

XGN vs NOTV Comparison

Compare XGN & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XGN
  • NOTV
  • Stock Information
  • Founded
  • XGN 2002
  • NOTV 1974
  • Country
  • XGN United States
  • NOTV United States
  • Employees
  • XGN N/A
  • NOTV N/A
  • Industry
  • XGN Medical Specialities
  • NOTV Biotechnology: Pharmaceutical Preparations
  • Sector
  • XGN Health Care
  • NOTV Health Care
  • Exchange
  • XGN Nasdaq
  • NOTV Nasdaq
  • Market Cap
  • XGN 44.7M
  • NOTV 40.4M
  • IPO Year
  • XGN 2019
  • NOTV 1997
  • Fundamental
  • Price
  • XGN $2.98
  • NOTV $2.68
  • Analyst Decision
  • XGN Buy
  • NOTV Strong Buy
  • Analyst Count
  • XGN 1
  • NOTV 3
  • Target Price
  • XGN $7.00
  • NOTV $5.92
  • AVG Volume (30 Days)
  • XGN 21.5K
  • NOTV 321.7K
  • Earning Date
  • XGN 11-12-2024
  • NOTV 12-09-2024
  • Dividend Yield
  • XGN N/A
  • NOTV N/A
  • EPS Growth
  • XGN N/A
  • NOTV N/A
  • EPS
  • XGN N/A
  • NOTV N/A
  • Revenue
  • XGN $55,751,000.00
  • NOTV $501,062,000.00
  • Revenue This Year
  • XGN $9.98
  • NOTV N/A
  • Revenue Next Year
  • XGN $13.63
  • NOTV $8.69
  • P/E Ratio
  • XGN N/A
  • NOTV N/A
  • Revenue Growth
  • XGN 8.00
  • NOTV N/A
  • 52 Week Low
  • XGN $1.30
  • NOTV $1.23
  • 52 Week High
  • XGN $3.71
  • NOTV $11.42
  • Technical
  • Relative Strength Index (RSI)
  • XGN 58.94
  • NOTV 62.39
  • Support Level
  • XGN $2.62
  • NOTV $1.71
  • Resistance Level
  • XGN $2.97
  • NOTV $3.60
  • Average True Range (ATR)
  • XGN 0.21
  • NOTV 0.34
  • MACD
  • XGN 0.05
  • NOTV 0.07
  • Stochastic Oscillator
  • XGN 83.33
  • NOTV 51.58

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

Share on Social Networks: